版本:
中国

BRIEF-Veracyte says Anthem coverage for the Afirma gene expression classifier for use in thyroid cancer diagnosis

May 18 Veracyte Inc

* Veracyte announces Anthem coverage for the Afirma® gene expression classifier for use in thyroid cancer diagnosis

* Anthem Inc has issued positive coverage policy veracyte's Afirma Gene Expression Classifier (GEC) for use in thyroid cancer diagnosis Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐